BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4080642)

  • 1. Induction of cell mediated immunity in vitro and in vivo after cis-platin treatment.
    Bahadur A; Sodhi A
    Pol J Pharmacol Pharm; 1985; 37(4):453-61. PubMed ID: 4080642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin.
    Bahadur A
    Pol J Pharmacol Pharm; 1985; 37(4):463-8. PubMed ID: 4080643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cell mediated immunity in mice after cisplatin treatment.
    Bahadur A; Sarna S; Sodhi A
    Pol J Pharmacol Pharm; 1984; 36(5):441-8. PubMed ID: 6543466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible mechanism of tumor regression in cisplatin-treated mice.
    Sarna S; Sodhi A; Bhola RK
    Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice.
    Prasad SB; Rosangkima G; Kharbangar A
    Mitochondrion; 2010 Jan; 10(1):38-45. PubMed ID: 19766736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cis-dichlorodiammine platinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin.
    Prasad SB; Sodhi A
    Chem Biol Interact; 1981 Sep; 36(3):355-67. PubMed ID: 6895188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V; Müerköster S; Umansky V
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
    Koyama S; Yoshioka T; Sakita T
    Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The success of locoregional, low-dose recombinant interleukin-2 therapy in tumor-bearing mice is dependent on the time of rIL-2 administration.
    Everse LA; Bernsen MR; Dullens HF; Den Otter W
    J Exp Ther Oncol; 1996 Jul; 1(4):231-6. PubMed ID: 9414409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
    Kaido TJ; Maury C; Gresser I
    Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
    Gupta V; Singh SM
    Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural observations on the effect of cis-dichlorodiammine platinum (II) on the cells of fibrosarcoma in Swiss white mice.
    Sodhi A; Sarna S
    Indian J Exp Biol; 1979 Jan; 17(1):1-8. PubMed ID: 468314
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
    Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
    Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in cell-mediated immune functions induced in mouse splenic lymphocytes by polycyclic aromatic hydrocarbons.
    Wojdani A; Alfred LJ
    Cancer Res; 1984 Mar; 44(3):942-5. PubMed ID: 6420057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.